Sumitomo Chemical Company (SCC), parent company of Valent U.S.A. and Valent BioSciences, announced senior executive appointments, effective April 1.

Matt Plitt, Executive Vice President and COO of Valent U.S.A. since 2014, has been appointed President and CEO of Valent U.S.A., which includes subsidiaries Valent de Mexico and Valent Canada. Plitt joined Valent in 2010 as Vice President, Sales.

Plitt will report to Juan Ferreira, who has been named Managing Executive Officer of SCC and Executive Vice Chair of Valent U.S.A. Ferreira joined Sumitomo Chemical in 2019. He leads and manages the business for the Latin America region. He has served as a global advisor to SCC’s Health & Crop Sciences Sector including the Valent group of companies and now becomes the Executive Vice Chair of the Valent U.S.A. Board of Directors.

This will enable greater collaboration and innovation across North and South America. Ferreira will continue to report to Dr. Nobuaki Mito, Representative Director & Senior Managing Executive Officer (President of the Health & Crop Sciences Sector), Sumitomo Chemical.

Ted Melnik, Executive Vice President and COO of Valent BioSciences (VBC) has been named President and CEO of Valent BioSciences, which includes Pace International and Mycorrhizal Applications. He was named COO of VBC in 2013 and is leading the expansion of the global biorational business, a major focus area for Sumitomo Chemical. Melnik will continue to report to Dr. Nobuaki Mito.

Andy Lee, President and CEO of Valent U.S.A., and Valent BioSciences has been appointed President and CEO of a newly created company that will integrate and provided corporate services across the Valent group of companies.

Lee will continue to report to Dr. Nobuaki Mito and will serve on the Board of Directors for Valent U.S.A. and VBC. Lee has served in key leadership roles in the North American agriculture industry and has led diverse teams and complex enterprise integration initiatives across the Valent group since 2011.